Back to results
US 2020/0345734 A1Published application
Methods of treating ocular conditions
AssigneeOyster Point Pharma, Inc.
InventorsDouglas Michael ACKERMANN, James LOUDIN, Kenneth J. MANDELL
Life of this patent
Estimating the term…
Abstract
Described herein are methods and pharmaceutical formulations for treating ocular conditions.
Claims20
1-61. (canceled)
A method for increasing the amount or concentration of one or more lacrimal proteins produced by an individual in need thereof, comprising local administration of a therapeutically effective amount of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine, or a pharmaceutically acceptable salt thereof, in alternating nostrils of an individual in need thereof,
- wherein the therapeutically effective amount per dose is between 1 microgram and 5 milligrams of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine, or a pharmaceutically acceptable salt thereof, per dose.
Dependencies are inferred from the claim text.